These novel medications , including Semaglutide , Tirzepatide , and Retatrutide , represent a major advancement in managing type 2 the condition and promoting weight loss . They function by imitating the body’s natural incretin GLP-1 , enabling to moderate blood glucose and decrease appetite . Each drug has slightly distinct characteristics and m